AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Larry Lane doesn't mince words when it comes to assessing the federal government's new Medicare prescription benefit.
"It's a mess," he says plainly. The declaration speaks volumes, for Lane has dealt with governmental relations at the highest level for decades.
"I can go through nightmare scenarios forever," he continues. The vice president for governmental relations for nursing home giant Genesis Health Ventures, Lane and countless other stakeholders had anxiously awaited the government's final rule for the Medicare Prescription Drug, Improvement and Modernization Act. The 1,500-page rule finally came out late Jan. 21, not leaving enough time for them to comment for this article.
They were desperately hoping for clues as to how drug administration is to be changed for more than 1 million nursing home residents by Jan. 1.
When Congress narrowly passed the controversial Medicare reform act in late 2003, it decreed drastic coverage changes. But it also neglected to give any details as to how nursing home residents--who have enormous drug needs and are served by specialty pharmacies--should be served.
About 11 months is all that regulators, providers and pharmacies have to get it right. That's not a long time.
"It's not difficult to write a terrible, meltdown scenario here," said Paul Baldwin, executive director of the Long Term Care Pharmacy Alliance, an advocacy group for the four major U.S. nursing home pharmacy companies.
Source: HighBeam Research, Medi-chaos? Nursing home operators and pharmacies worry about how...